Wednesday, June 24, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 875 of 1,261

  1. US 8426444

    Oxabicycloheptanes and oxabicycloheptenes, their preparation and use

    Lixte Biotechnology, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  2. US 8426445

    Iminosugars and methods of treating bunyaviral and togaviral diseases

    United Therapeutics Corporation · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  3. US 8426436

    Heterocyclic cyclopamine analogs and methods of use thereof

    Infinity Discovery, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  4. US 8426432

    Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties

    UNIVERSITY OF CONNECTICUT · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  5. US 8426426

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  6. US 8426414

    Modulators of G protein-coupled receptor 88

    LEXICON PHARMACEUTICALS, INC. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  7. US 8426385

    Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof

    Hainan Hdeton Science and Technology Co., Ltd. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  8. US 8426449

    Aminoalkylphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  9. US 8426474

    Antimicrobial wash and carrier solutions and uses thereof

    Teva Animal Health, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  10. US 8425930

    Prebiotic oligosaccharides

    The Regents of the University of California · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  11. US 8426188

    Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  12. US 8426179

    Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme

    Northwestern University · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  13. US 8425933

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  14. US 8426365

    Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  15. US 8426379

    POT1 alternative splicing variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  16. US 8425653

    Plasmon mediated photoinduced synthesis of silver triangular bipyramids

    Northwestern University · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  17. US 8425492

    In vivo device, system and usage thereof

    Julius-Maximilians-Universitat Wurzburg · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  18. US 8425459

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Lutonix, Inc. · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  19. US 8425447

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  20. US 8425446

    Selective cytopheresis devices and related methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  21. US 8425445

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  22. US 8426433

    Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution

    Obschestvo S Ogranichennoi Otvetsttvennoctiyu “Bionika” · Granted Apr 23, 2013 · Expires Apr 18, 2033

    granted

  23. CA 2852995

    COMPOSITION OPHTALMIQUE QUI CONTIENT DU BROMFENAC PRESENTANT UNE BIODISPONIBILITE ACCRUE

    BAUSCH & LOMB [US] · Granted Apr 18, 2013 · Expires Apr 13, 2033

    granted

  24. US 8420620

    Induced internalization of surface receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.